Intermittent Hypoxic Preconditioning: A Potential New Powerful Strategy for COVID-19 Rehabilitation
Pharmacology
[키워드] ACE2 receptor
applied
biochemical
Cardiopulmonary
cardiorespiratory
cardiovascular systems
cause
chronic obstructive
clinical
clinical study
COPD
Coronary heart disease
COVID-19
death
diabetes
dysfunction
Dyspnea
effective drug
function
heart failure
HIF-1α
host cells
hypertension
hypoxic
immune function
immune response
IMPROVE
Inflammation
Inflammatory cytokine storm
Intermittent
intermittent hypoxic preconditioning
Ischemia
mechanism
New
organ
other diseases
oxidative stress
pathophysiology
Patient
patients with COVID-19
physiological
Pneumonia
Potential
Prognosis
proliferate
pulmonary disease
rehabilitation
Respiratory failure
Respiratory system
respiratory virus
Safe
severe cases
Strategy
the disease
tissue
Tolerance
Treatment
Vaccine
virus
[DOI] 10.3389/fphar.2021.643619 PMC 바로가기 [Article Type] Pharmacology
[DOI] 10.3389/fphar.2021.643619 PMC 바로가기 [Article Type] Pharmacology